Gossamer Bio, Inc. GOSS
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -45.51% | 22.87% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -45.51% | 22.87% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -45.51% | 22.87% | |||
| SG&A Expenses | -52.52% | 71.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -42.88% | 3.31% | |||
| Operating Income | 41.88% | 2.55% | |||
| Income Before Tax | 136.22% | 1.40% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 136.22% | 1.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 136.22% | 1.22% | |||
| EBIT | 41.88% | 2.55% | |||
| EBITDA | 41.89% | 2.55% | |||
| EPS Basic | 126.50% | 4.39% | |||
| Normalized Basic EPS | 57.75% | 12.82% | |||
| EPS Diluted | 61.59% | 4.39% | |||
| Normalized Diluted EPS | 58.88% | 12.82% | |||
| Average Basic Shares Outstanding | 36.68% | 3.32% | |||
| Average Diluted Shares Outstanding | 40.42% | 3.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||